Synnestvedt M - Search Results

1

Melanoma of unknown primary site: presentation, treatment, and prognosis--a single institution study. University of Pennsylvania Pigmented Lesion Study Group.

Anbari KK, Schuchter LM, Bucky LP, Mick R, Synnestvedt M, Guerry D 4th, Hamilton R, Halpern AC. Anbari KK, et al. Among authors: synnestvedt m. Cancer. 1997 May 1;79(9):1816-21. doi: 10.1002/(sici)1097-0142(19970501)79:9<1816::aid-cncr26>3.0.co;2-#. Cancer. 1997. PMID: 9129001

2

Multiple primary melanoma revisited.

Blackwood MA, Holmes R, Synnestvedt M, Young M, George C, Yang H, Elder DE, Schuchter LM, Guerry D, Ganguly A. Blackwood MA, et al. Among authors: synnestvedt m. Cancer. 2002 Apr 15;94(8):2248-55. doi: 10.1002/cncr.10454. Cancer. 2002. PMID: 12001124 Free article.

3

Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma. A case-control study.

Halpern AC, Guerry D 4th, Elder DE, Clark WH Jr, Synnestvedt M, Norman S, Ayerle R. Halpern AC, et al. Among authors: synnestvedt m. Arch Dermatol. 1991 Jul;127(7):995-9. Arch Dermatol. 1991. PMID: 2064418

4

Model predicting survival in stage I melanoma based on tumor progression.

Clark WH Jr, Elder DE, Guerry D 4th, Braitman LE, Trock BJ, Schultz D, Synnestvedt M, Halpern AC. Clark WH Jr, et al. Among authors: synnestvedt m. J Natl Cancer Inst. 1989 Dec 20;81(24):1893-904. doi: 10.1093/jnci/81.24.1893. J Natl Cancer Inst. 1989. PMID: 2593166

5

Dysplastic nevi as a melanoma risk factor in patients with familial melanoma.

Carey WP Jr, Thompson CJ, Synnestvedt M, Guerry D 4th, Halpern A, Schultz D, Elder DE. Carey WP Jr, et al. Among authors: synnestvedt m. Cancer. 1994 Dec 15;74(12):3118-25. doi: 10.1002/1097-0142(19941215)74:12<3118::aid-cncr2820741210>3.0.co;2-7. Cancer. 1994. PMID: 7982177

6

A cohort study of melanoma in patients with dysplastic nevi.

Halpern AC, Guerry D 4th, Elder DE, Trock B, Synnestvedt M. Halpern AC, et al. Among authors: synnestvedt m. J Invest Dermatol. 1993 Mar;100(3):346S-349S. doi: 10.1111/1523-1747.ep12470256. J Invest Dermatol. 1993. PMID: 8440922 Free article.

7

A prognostic model for predicting 10-year survival in patients with primary melanoma. The Pigmented Lesion Group.

Schuchter L, Schultz DJ, Synnestvedt M, Trock BJ, Guerry D, Elder DE, Elenitsas R, Clark WH, Halpern AC. Schuchter L, et al. Among authors: synnestvedt m. Ann Intern Med. 1996 Sep 1;125(5):369-75. doi: 10.7326/0003-4819-125-5-199609010-00003. Ann Intern Med. 1996. PMID: 8702087

8

Locally recurrent malignant melanoma characteristics and outcomes: a single-institution study.

Wildemore JK 4th, Schuchter L, Mick R, Synnestvedt M, Elenitsas R, Bedrosian I, Czerniecki BJ, Guerry D 4th, Lessin SR, Elder DE, Bucky LP. Wildemore JK 4th, et al. Among authors: synnestvedt m. Ann Plast Surg. 2001 May;46(5):488-94. doi: 10.1097/00000637-200105000-00006. Ann Plast Surg. 2001. PMID: 11352421

9

Loco-regional nodal relapse in melanoma.

Miller EJ, Daly JM, Synnestvedt M, Schultz D, Elder D, Guerry D 4th. Miller EJ, et al. Among authors: synnestvedt m. Surg Oncol. 1992 Oct;1(5):333-40. doi: 10.1016/0960-7404(92)90033-h. Surg Oncol. 1992. PMID: 1341268

10

A comparison of local recurrence and resection margins for stage I primary cutaneous malignant melanomas.

Zeitels J, LaRossa D, Hamilton R, Synnestvedt M, Schultz D. Zeitels J, et al. Among authors: synnestvedt m. Plast Reconstr Surg. 1988 May;81(5):688-93. doi: 10.1097/00006534-198805000-00007. Plast Reconstr Surg. 1988. PMID: 3362987

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

68 results

Search Page